Chronic Lymphocytic Leukemia Therapy
Reports summarize chronic lymphocytic leukemia therapy research from Food & Drug Administration
Published in Blood Weekly, March 27th, 2008
New research, 'FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia,' is the subject of a report. According to recent research from the United States, "On September 19, 2007, the U.S. Food and Drug Administration granted regular approval and expanded labeling for alemtuzumab (Campath); Genzyme Corporation, Cambridge, MA) as single-agent treatment for B-cell chronic lymphocytic leukemia (B-CLL)."
"Alemtuzumab was initially approved in 2001 under accelerated approval regulations. Conversion to regular approval was based on a single study submitted to verify clinical benefit. Efficacy and safety were demonstrated in an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-03-27)
More Articles from Blood Weekly
- Biomedicine
Overweight, obese women improve quality of life with 10 to 30 minutes of exercise - Liver Transplant
A new finding in liver transplantation and antifibrinolytics? - Tissue Engineering
Is increased Slug expression associated with the progression to esophageal cancer? - Acute Myelogenous Leukemia
Study results from University of Massachusetts provide new insights into acute myelogenous leukemia - Acute Myeloid Leukemia
Research from University of Texas provides new data about acute myeloid leukemia - Alpha-thalassemia
Research data from National University update understanding of alpha-thalassemia - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
